$36.37
-1.63 (-4.29%)
Open$38.09
Previous Close$38.00
Day High$38.20
Day Low$36.08
52W High$43.25
52W Low$20.65
Volume—
Avg Volume1.61M
Market Cap2.62B
P/E Ratio—
EPS$-2.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
21 analysts
Price Target
-38.4% upside
Current
$36.37
$36.37
Target
$22.40
$22.40
$12.72
$22.40 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 601.07M | 622.81M | 541.11M |
| Net Income | 107.25M | 120.49M | 94.92M |
| Profit Margin | 17.8% | 19.4% | 17.5% |
| EBITDA | 198.86M | 206.18M | 175.68M |
| Free Cash Flow | 71.76M | 51.92M | 65.95M |
| Rev Growth | +10.0% | +14.9% | +24.5% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |